Related Experiment Video

Updated: Jun 17, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Is it time to discard beta-blockers in patients undergoing noncardiac surgery?

José López-Sendón1, Eduardo Alegría

  • 1Cardiology Department, La Paz University Hospital, Madrid, Spain. jlsendon@terra.es

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|December 17, 2009
PubMed

Insights

Beta-blocker therapy is recommended for patients undergoing major surgery, similar to other common conditions. Risk stratification is crucial to identify patients with coronary artery disease (CAD) or ischemia for appropriate treatment.

Area of Science:

  • Cardiology
  • Perioperative Medicine
  • Pharmacology

Background:

  • Cardiac complications are a significant concern in patients undergoing major surgical or vascular procedures.
  • Beta-adrenoceptor antagonists (beta-blockers) are established treatments for various cardiovascular conditions.

Purpose of the Study:

  • To evaluate the role of beta-blocker therapy in preventing cardiac complications in patients undergoing major surgery.
  • To determine the appropriate timing and dosage of beta-blockers in the perioperative setting.

Main Methods:

  • Review of current guidelines and evidence regarding beta-blocker use in patients with established cardiovascular disease.
  • Analysis of the risks and benefits of initiating beta-blocker therapy in the perioperative period.

Main Results:

  • Beta-blockers are indicated for patients with acute coronary syndrome, systolic dysfunction, chronic coronary artery disease (CAD), vascular disease, and diabetes, regardless of surgical candidacy.
  • Risk stratification is necessary to identify patients with pre-existing CAD or myocardial ischemia.
  • Initiating high-dose beta-blockers immediately before surgery is associated with an increased risk of hypotensive strokes.

Conclusions:

  • Beta-blocker therapy should be considered for patients undergoing major surgery, aligning with management in other clinical scenarios.
  • Perioperative risk stratification is essential for optimizing beta-blocker treatment in surgical patients.
  • Careful titration of beta-blockers is crucial to avoid adverse events like hypotensive strokes.

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...